Clinical trials query results
From Health Canada
- Medical condition:
- MESOTHELIOMA
- Medical condition:
- ADULT FEMALE,ADULT MALE
- Drug name:
- IMFINZI / TREMELIMUMAB / PROCYTOX
- Protocol title:
- SURGERY FOR MESOTHELIOMA AFTER RADIATION THERAPY USING EXQUISITE SYSTEMIC THERAPY
- Sponsor name:
- UNIVERSITY HEALTH NETWORK
- Date of no objection letter:
- 2022-04-08
- Control number:
- 261968
- Trial status:
- ONGOING
- Date study started:
- 2024-01-15